Posts in category Events

Report Release Webinar

Preparing for Future Products of Biotechnology, a consensus report from the National Academies of Sciences, Engineering, and Medicine, was released on Thursday, March 9, 2017.

View Release Presentation Slides Here

The report describes the new types of biotechnology products likely to emerge over the next 5-10 years and assesses whether future products could pose different types of risks relative to existing products. It also identifies the scientific capabilities, tools, and expertise needed to support the oversight of these products by the U.S. regulatory system.

Watch The Webinar Recording Below

The report release briefing featured:

– Welcome and introductions

  • Bruce B. Darling, Executive Officer, National Academies of Sciences, Engineering, and Medicine

– A presentation by the Chair of the report’s authoring committee

  • Dr. Richard M. Murray, Member of the National Academy of Engineering, Thomas E. and Doris Everhart Professor of Control and Dynamical Systems and Bioengineering, California Institute of Technology

– A Q&A session with study committee members

  • Dr. Richard M. Murray, Member of the National Academy of Engineering, Thomas E. and Doris Everhart Professor of Control and Dynamical Systems and Bioengineering, California Institute of Technology
  • Dr. Steven P. Bradbury, Professor of Environmental Toxicology, Iowa State University
  • Dr. Mary E. Maxon, Biosciences Area Principal Deputy, Lawrence Berkeley National Laboratory

Webinar: Assessing the Environmental Impact of Synthetic Biology

Monday, August 1, 2016 at 2:00 pm Eastern

Watch the webinar recording below. View slides


Chris Warner, US Army Engineer Research & Development Center. View bio

Chris Warner, Ph.D., is a biochemist and biochemical engineer in the Environmental Laboratory at the USACE Engineer Research and Development Center. He has experience in fundamental academic research, pharmaceutical product development and military material projects. Chris is interested how biological systems can be understood to guide synthesis of new materials and novel solutions to existing problems. Dr. Warner has been with the Environmental Lab since 2012, where he helped develop synthetic biology and bio-inspired material synthesis programs. Prior to joining ERDC, Chris was a doctoral research candidate with the Keck Graduate School of Applied Life Sciences (KGI). His work helped to develop manufacturing techniques to provide medical countermeasures in the event of a catastrophic biological event, such as a pandemic or detonation of a biological weapon. Dr. Warner previously worked at Regeneron Pharmaceuticals, where he helped develop lifesaving cancer medicines for hard to treat tumors. His education includes a B.S in Neuroscience and a B.S. in Biochemistry from UCLA, as well as a Masters in Applied Life Sciences from KGI, a PhD in Biochemical Engineering from KGI and a MBA in Business Administration with an emphasis in Marketing and Finance from the Drucker School of Business in Claremont, CA.

Jed Eberly, Research Microbiologist, US Army Engineer Research & Development Center. View bio

Jed Eberly, Ph.D., is a Research Microbiologist in the Environmental Laboratory at the USACE Engineer Research and Development Center. He is the principle investigator for multiple projects in the ERDC Environmental Quality and Installations (EQ/I) program. His areas of study include synthetic microbial circuits for analyzing signal transmission in feed forward loops and aptamers for detection of insensitive munitions. He is also lead PI for a project focused and improving early detection of harmful algal blooms (HABs) and HAB toxin release. In conjunction with this work he supports multiple USACE Corps districts by assisting with developing plans for mitigating HABs. His most recent area of study is in assessing the environmental impacts of synthetic biology. Dr. Eberly holds a doctorate degree in Biological and Ecological Engineering from Oregon State University.

The webinar is an information-gathering meeting for the committee in which the speakers are invited to provide input to the committee. The webinar will be recorded and posted on this page.

Webinar: An Overview of the TSCA Updates

Tuesday, August 2, 2016 at 1:00 pm Eastern

Watch the webinar recording below. View slides


Lynn Bergeson, Managing Partner, Bergeson & Campbell PC. View bio

Owner of Bergeson & Campbell, P.C. (B&C®), Ms. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, biotechnology, and other emerging transformative technologies. Her knowledge of and involvement in the policy process allows her to develop client-focused strategies whether advocating before Congress, the U.S. Environmental Protection Agency (EPA), the U.S. Food and Drug Administration (FDA), or other governance and standard-setting bodies.
Ms. Bergeson counsels corporations, trade associations, and business consortia on a wide range of issues pertaining to chemical hazard, exposure and risk assessment, risk communication, minimizing legal liability, and evolving regulatory and policy matters pertinent to products of conventional, biotechnology, biobased chemicals, nanotechnologies, and other emerging technologies, particularly with respect to TSCA, FIFRA, Food Quality Protection Act (FQPA), REACH and REACH-like programs, and Occupational Safety and Health Administration (OSHA) matters.

The webinar is an information-gathering meeting for the committee in which the speakers are invited to provide input to the committee. The webinar will be recorded and posted on this page.

Webinar: Synthetic Nature and the Future of Conservation

Tuesday, August 2, 2016 at 2:00 pm Eastern

Watch the webinar recording below. View slides


Kent Redford, Principal, Archipelago Consulting. View bio

Kent H. Redford is the principal at Archipelago Consulting, established in 2011 and based in Portland, Maine. In 1993 he left academia to join The Nature Conservancy (TNC) where until 1997, he directed the Parks in Peril program and ran the conservation science department in the Latin American Division. At TNC he helped develop guidelines for ecoregion-based conservation in the US and abroad and was a member of the Conservation Committee that developed a conservation mission for the whole organization. In 1997 he joined the Wildlife Conservation Society to work in the International Program on conservation strategy. He was then chosen to lead the WCS Institute, created to: 1) analyze conservation and academic trends that potentially challenge WCS’s mission or provide opportunities to further conservation effectiveness; and 2) to communicate strategically with significant stakeholders, including other conservation NGOs and the private sector. The Institute drew on WCS’s wide range of conservation issues, and disseminated WCS’s conservation work via papers and workshops, adding value to WCS’s discoveries and experience by sharing them with partner organizations, policy-makers, and the public. Through his career Kent has continued to actively publish on conservation practice and the biology of mammals.

The webinar is an information-gathering meeting for the committee in which the speakers are invited to provide input to the committee. The webinar will be recorded and posted on this page.

Webinar: Re-Envisioning Risk Assessment

Friday, July 22, 2016 at 2-4 pm Eastern

Watch the webinar recording below


Kristen C. Nelson, Professor, University of Minnesota. View bio (view slides)

As an environmental sociologist, Dr. Kristen C. Nelson contributes to the interdisciplinary understanding of environmental change and human systems. Her recent research focuses on urban ecosystems (household choices and community planning), environmental risk assessment and multi-stakeholder deliberation, anticipatory governance and policy formation, and the dynamics of social networks. Her contributions to environmental risk assessment focus on methodological development for Problem Formulation and Option Assessment (PFOA) though eight peer-reviewed book chapters, a journal article, a decision maker-manager handbook, and numerous presentations/consultations. In all environmental issues her interest is in providing theoretical and practical insights regarding what influences human behavior and societal change at multiple scales. At the University of Minnesota, she is a H.T. Morse Faculty Award recipient and Professor in the Department of Forest Resources and the Department of Fisheries, Wildlife and Conservation Biology. Her collaborative projects in the U.S. include work with the U.S. Forest Service, U.S. Fisheries and Wildlife Service, Minnesota DNR, Minnesota MPCA as well as numerous cities and counties. Internationally her collaborative projects have been with Rockefeller Foundation as well as scientists, managers, and decision makers in Switzerland, Kenya, Brazil, Nicaragua, Chile, Mexico, Vietnam, Malaysia, and China.

Steve Mashuda, Managing Attorney for Oceans, Earth Justice. View bio (view slides)

Steve Mashuda is the Managing Attorney for Oceans at Earthjustice. He began working for Earthjustice’s Northern Rockies office in 1998, where he specialized in Clean Water Act and Endangered Species Act litigation. In 2000, he joined Earthjustice in Seattle, where he has focused primarily on Northwest salmon recovery, including 15 years of litigation to protect and recover salmon and steelhead in the Columbia and Snake Rivers. Steve joined Earthjustice’s Oceans Program in 2014 where he works with the organization’s ocean litigators to promote sustainable fisheries and healthy ocean ecosystems, safeguard marine species, and build resilience to climate change.

Tichafa Munyikwa, Global Regulatory Affairs Lead, Syngenta. View bio (view slides)

Dr. Tichafa “Tich” Munyikwa is Global Regulatory Affairs Lead at Syngenta. His area of responsibly covers global registrations for new biotechnology traits such as Plant Breeding Innovations, RNA interference (RNAi), Biopesticides, and Genetically Modified traits in various crops. Tich has over twenty years’ experience in the field of plant biotechnology developing and utilizing novel technology approaches to solve production, disease and pest issues of crops. He is an inventor with several biotechnology patents and a regulatory scientist with working knowledge of global regulations of GM crops. Dr. Munyikwa received his Ph.D. in Cell and Molecular Biology from Wageningen University (The Netherlands).

Zahra Meghani, Associate Professor, Philosophy Department, University of Rhode Island. View bio

As a philosopher with a specialization in ethics, Dr. Zahra Meghani’s work is in the area of environmental ethics. She has a number of peer reviewed publications on the normativity of risk assessment of genetically engineered food. In particular, she examines the influence of neoliberalism on the US food regulatory system. Her aim is to identify and develop the theoretical underpinnings of a regulatory review process for genetically modified food that is transparent, unbiased, inclusive and democratic. She is also engaged in health care ethics research. The inequitable distribution of health care resources between different groups at the national and international level is the focus of her research. She is an Associate Professor in the Philosophy Department at the University of Rhode Island.

The webinar is an information-gathering meeting for the committee in which the speakers are invited to provide input to the committee. The webinar will be recorded and posted on this page.

Webinar: Screening Tools

Friday, July 29, 2016 at 1 – 3 pm Eastern

Watch the webinar recording below


John Yates, Professor, The Scripps Research Institute. View bio. (view slides)

Dr. John Yates is currently the Ernest W. Hahn Professor of Chemical Physiology and Molecular and Cellular Neurobiology at The Scripps Research Institute. His research background involves development of integrated methods for tandem mass spectrometry analysis of protein mixtures, bioinformatics using mass spectrometry data, and biological studies involving proteomics. Dr. Yates is the lead inventor of the SEQUEST software for correlating tandem mass spectrometry data to sequences in the database and principle developer of the shotgun proteomics technique for the analysis of protein mixtures. His laboratory has developed the use of proteomic techniques to analyze protein complexes, posttranslational modifications, organelles and quantitative analysis of protein expression for the discovery of new biology. Dr. Yates has recently led a NIDCR funded Center to characterize the Saliva proteome and have been involved in a NCRR funded Research Resource Center for the last 15 years and was involved in an NSF funded Science and Technology Center for 10 years. Dr Yates has his B.A. in Zoology from the University of Maine, M.S. in Chemistry from the University of Maine, and Ph.D. in Biology from the University of Virginia.

John Ryals, President and Chief Executive Officer, Metabolon. View bio (view slides)

Dr. John Ryals co-founded Metabolon, Inc. in 2002 and serves as president and CEO. Metabolon is a pioneer and leader in the field of metabolomics and its use in precision medicine and human health. Prior to Metabolon, he was a co-founder, CEO and president of Paradigm Genetics, Inc., a publicly traded agricultural biotechnology company focused on industrializing the process of gene function discovery. Dr. Ryals has 30 years of experience in the biotechnology industry, including senior research positions at Novartis and Ciba-Geigy. He currently serves on the board of directors at AgBiome, a provider of early-stage R&D for agriculture, and the advisory board of the College of Agriculture and Life Sciences at North Carolina State University. He earned a B.A. in biology and chemistry from the University of North Texas and M.S. and Ph.D. degrees in molecular biology from the University of Texas at Dallas.

Dan Schlenk, Professor, University of California, Riverside. View bio (view slides)

Daniel Schlenk, Ph.D. is Professor of Aquatic Ecotoxicology and Environmental Toxicology at the University of California Riverside. Dr. Schlenk received his PhD in Toxicology from Oregon State University in 1989. He was supported by a National Institute of Environmental Health Science postdoctoral fellowship at Duke University from 1989-1991. He is a Fellow of the American Association for the Advancement of Science, and from 2007-2014, he was a permanent member of the USEPA FIFRA Science Advisory Panel which he chaired from 2012-2014. He is currently a member of the USEPA Chemical Safety Advisory Committee, and from 2003-2006, he was a member of the Board of Directors for the North American Society of Environmental Toxicology and Chemistry. He is on the editorial boards of Toxicological Sciences, Marine Environmental Research and Aquatic Toxicology, of which he was co-editor-in chief from 2005-2011. He has published more than 220 peer reviewed journal articles and book chapters. He has been a recipient of the Ray Lankester Investigatorship of the Marine Biological Association of the United Kingdom; a visiting Scholar of the Instituto Del Mare, Venice Italy; a visiting Scholar in the Department of Biochemistry, Chinese University of Hong Kong; a Visiting Scientist at the CSIRO Lucas Heights Laboratory, in Sydney Australia, a Distinguished Fellow of the State Key Laboratory for Marine Environmental Science of Xiamen University, China, and a Visiting Professor Fellow of the National Counsel of Technological and Scientific Development at the University of Sao Jose Rio Preto, Brazil . He has been an external reviewer for the School of Life Sciences at Chinese University of Hong Kong and an ad hoc member for the USEPA Science Advisory Board for Aquatic Life Criteria Guidelines from the Ecological Processes and Effects Committee. He has also participated in proposal review panels for the NSF, USEPA, NOAA, and the National Institute of Environmental Health Sciences Superfund Research Program. His research interests focus upon mechanisms of action of pesticides, PAHs, and emerging compounds on neuroendocrine targets. Dr. Schlenk’s research is funded by the National Institutes of Environmental Health Sciences Superfund Research Program, the Gulf of Mexico Research Initiative, the State of California, and other Federal Agencies.

The webinar is an information-gathering meeting for the committee in which the speakers are invited to provide input to the committee. The webinar will be recorded and posted on this page.

Webinar: Gene Drives

Thursday, July 28, 2016 at 3 – 5 pm Eastern

Watch the webinar recording below


Kevin Esvelt, Assistant Professor, MIT Media Lab – Massachusetts Institute of Technology. View bio (view slides)

Kevin Esvelt is an assistant professor of MIT and leader of the Sculpting Evolution group at the MIT Media Lab, which specializes in developing tools to reshape populations and ecosystems. An evolutionary engineer, Esvelt received his Ph.D. from Harvard University in 2010 for inventing a synthetic microbial ecosystem for rapidly evolving useful biomolecules. As a Technology Development Fellow of the Wyss Institute, he helped pioneer the development of a powerful new method of genome engineering based on CRISPR/Cas9, an enzymatic scalpel that can be programmed to cut DNA at any desired sequence. In 2014, Esvelt and his team were the first to outline how CRISPR could be used to build evolutionarily stable “gene drives” capable of altering wild populations of sexually reproducing organisms. Recognizing the potential implications of a unilateral method of reshaping shared ecosystems, he and his colleagues detailed ways to control, block, or even reverse changes made by gene drives while emphasizing the importance of laboratory safeguards to ensure they do not accidentally escape the laboratory. To set an example for future research in this field, they chose to reveal their findings before experimenting with CRISPR gene drives in the laboratory so that public notification and discussion could guide research and safeguards. There is little precedent for deciding whether, when, and how to use “collective” technologies whose deployment can affect entire communities. In addition to exploring ecological and evolutionary engineering, Esvelt seeks to establish a new model of open and responsive science in which revealed community expectations guide the development of powerful technologies with shared impacts.

Elizabeth Heitman, Associate Professor, Center for Biomedical Ethics and Society – Vanderbilt University Medical Center and Cochair of Academies Gene Drives Report. View bio (view slides)

Elizabeth Heitman, PhD, was cochair of the National Academy of Sciences, Engineering, and Medicine’s committee on Gene Drives on the Horizon: Advancing Science, Navigating Uncertainty, and Aligning Research with Public Values. She is currently an Associate Professor of Medical Ethics in the Center for Biomedical Ethics and Society at Vanderbilt University Medical Center. Dr. Heitman’s work focuses on cultural issues and international aspects of ethics in medicine, biomedical science, and public health. Her research examines international standards of research ethics, education in the responsible conduct of research, and trainees’ awareness of professional and cultural norms. She is co-director of the research ethics education program “Formação Colaborativa na Ética em Pesquisa (Collaborative Research Ethics Education)”, sponsored by the NIH Fogarty International Center, with colleagues from the Universidade Eduardo Mondlane in Maputo, Mozambique. Dr. Heitman previously directed a similar program with the Hospital Nacional de Niños in San José, Costa Rica and was PI of the National Science Foundation-funded study “Research Integrity in the Education of International Science Trainees.” Dr. Heitman leads the research ethics activities of the Vanderbilt Institute for Clinical and Translational Research (VICTR), and coordinates VICTR’s educational programs in the responsible conduct of research. She is a member of the National Academy of Science’s (NAS) Board on Life Sciences, and its Standing Committee on Educational Institutes for Teaching Responsible Science. Through the NAS, Dr. Heitman has served as a faculty member in international faculty development projects on responsible science in the Middle East and North Africa, as well as Malaysia and Indonesia. She recently chaired the NAS Committee on the Elaboration of a National Curriculum in Bioethics and Responsible Conduct of Science for Algeria, advising the Algerian Ministry of Higher Education. Since 2009 she has been a member of the American Association for the Advancement of Science’s (AAAS) Science Ethics Initiative with the China Association for Science and Technology, and has contributed to AAAS’s work on biosafety/ biosecurity education since 2008. Dr. Heitman received her PhD in Religious Studies in 1988 from Rice University’s joint program in biomedical ethics with the University of Texas – Houston Medical School.

The webinar is an information-gathering meeting for the committee in which the speakers are invited to provide input to the committee. The webinar will be recorded and posted on this page.

Webinar: Defense and Intelligence Agency Funding

Monday, July 25, 2016 at 12 – 1 pm Eastern

Watch the webinar recording below


Justin Gallivan, Program Manager-Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA). View bio (view slides)

Dr. Justin Gallivan joined the Defense Advanced Research Projects Agency in January 2014. He is interested in many facets of synthetic biology, including engineering microbial communities to produce small molecules or to prevent disease, and reprogramming multicellular organisms to perform complex tasks. Dr. Gallivan came to DARPA from Emory University, where he was an Associate Professor and a Winship Distinguished Research Professor in the Department of Chemistry. At Emory, he led a research program in RNA-based synthetic biology. Dr. Gallivan received a Bachelor of Science in Chemistry from the University of Illinois at Urbana-Champaign (1994) and a Doctor of Philosophy in Chemistry from the California Institute of Technology (2000), where he later completed a National Institutes of Health National Research Service Award postdoctoral fellowship. He has been a Fellow of the Alfred P. Sloan Foundation, a Camille Dreyfus Teacher-Scholar, a Beckman Young Investigator and a PopTech Science and Public Leadership Fellow.

John Julias, Program Manager Smart Collection, Intelligence Advanced Research Projects Activity (IARPA). View bio (view slides)

Dr. John Julias joined the Smart Collection Office at the Intelligence Advanced Research Projects Activity (IARPA) in December 2015. John’s research areas of interest include synthetic biology, emerging biological threats, and weapons of mass destruction.
Prior to coming to IARPA, John was a Program Manager in the Chem Bio Defense Division of the Homeland Security Advanced Research Projects Agency (HSARPA) in the Directorate of Science and Technology of the Department of Homeland Security. While at DHS, John managed programs in the areas of biosurveillance and pathogen characterization. From 2010-2014, Dr. Julias was a program manager at the Defense Advanced Research Projects Agency (DARPA) where he managed a diverse portfolio of research and development programs in the Strategic Technology Office and the Defense Sciences Office. The efforts included the development of technologies for intrinsic biocontainment, vaccine design and production, predicting pathogen evolution, and chemical collection and analysis. For his efforts on counter-pathogen technologies, he was the recipient of the SEC DEF Medal for Outstanding Public Service. Prior to joining DARPA, Dr. Julias was a science and technology consultant with Booz Allen Hamilton supporting clients at the Department of Defense as well as in the non-profit, global health area. Previously, he was a scientist at the National Cancer Institute-Frederick where he performed research on viral replication and drug resistance. Dr. Julias received a Ph.D. from the Department of Biochemistry at the West Virginia University School of Medicine (1997) and a Bachelor of Arts in Chemistry from Vanderbilt University (1991).

The webinar is an information-gathering meeting for the committee in which the speakers are invited to provide input to the committee. The webinar will be recorded and posted on this page.

Webinar: Safeguarding the Bioeconomy

Thursday, July 21, 2016 at 2-4 pm Eastern

Watch the webinar recording below


Gigi Kwik Gronvall, Senior Associate, University of Pittsburgh Medical Center-Center for Health Security. View bio (view slides)

Dr. Gronvall is a Senior Associate at the UPMC Center for Health Security and an Associate Professor at the University of Pittsburgh School of Medicine and Graduate School of Public Health. She is the author of Preparing for Bioterrorism: The Alfred P. Sloan Foundation’s Leadership in Biosecurity and is working on a book about the governance and risks of synthetic biology, to be published in fall 2016. Dr. Gronvall is a member of the Threat Reduction Advisory Committee (TRAC), which provides the Secretary of Defense with independent advice and recommendations on reducing the risk to the United States, its military forces, and its allies posed by nuclear, biological, chemical, and conventional threats. She served as the Science Advisor for the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism from April 2009 until the Commission ended in February 2010. She testified before Congress about the safety and security of high-containment biological laboratories in the US and to the Biological Weapons Convention (BWC) in Geneva, Switzerland.  Dr. Gronvall received a BS in biology from Indiana University, Bloomington and received a PhD from Johns Hopkins University for work on T-cell receptor/MHC I interactions. She was a National Research Council Postdoctoral Associate at the US Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick, Maryland.

Diane DiEuliis, Senior Research fellow, National Defense University. View bio (view slides)

Dr. Diane DiEuliis is a Senior Research fellow at National Defense University (NDU). Her research areas focus on emerging biological technologies, biodefense, and preparedness for biothreats. Dr. DiEuliis also studies issues related to dual use research, disaster recovery research, and behavioral, cognitive, and social science as it relates to important aspects of deterrence and preparedness. Prior to joining NDU, Dr. DiEuliis was the Deputy Director for Policy, (and served as Acting Deputy Assistant Secretary for Policy and Planning) in the Office of the Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services. From to 2007 to 2011, Dr. DiEuliis was the Assistant Director for Life Sciences and Behavioral and Social Sciences in the Office of Science and Technology Policy (OSTP) in the Executive Office of the President. During her tenure at the White House, she was responsible for developing policy in areas such as biosecurity, synthetic biology, social and behavioral science, scientific collections, ethics, STEM education, and biotechnology. Prior to working at OSTP, Dr. DiEuliis was a program director at the National Institutes of Health (NIH), where she managed a diverse portfolio of neuroscience research in neurodegenerative diseases. She completed a fellowship at the University of Pennsylvania in the Center for Neurodegenerative Disease Research, and completed her postdoctoral research in the NIH Intramural research program, where she focused on cellular and molecular neuroscience. Dr. DiEuliis has a Ph.D. in biology from the University of Delaware, in Newark, Delaware.

Edward You, Supervisory Special Agent,  Federal Bureau of Investigation-Weapons of Mass Destruction Directorate. View bio (view slides)

Edward You is a Supervisory Special Agent in the FBI’s Weapons of Mass Destruction Directorate, Biological Countermeasures Unit. Mr. You is responsible for creating programs and activities to coordinate and improve FBI and interagency efforts to identify, assess, and respond to biological threats or incidents. These efforts include expanding FBI outreach to the Life Sciences community to address biosecurity. Before being promoted to the Weapons of Mass Destruction Directorate, Mr. You was a member of the FBI Los Angeles Field Office Joint Terrorism Task Force and served on the FBI Hazardous Evidence Response Team. Mr. You has also been directly involved in policy-making efforts with a focus on biosecurity. He is an active Working Group member of the National Security Council Interagency Policy Committee on Countering Biological Threats and an Ex Officio member of the NIH National Science Advisory Board for Biosecurity. He also serves on two National Academies committees, the Institute of Medicine’s Forum on Microbial Threats and the Committee on Science, Technology, and Law’s Forum on Synthetic Biology. Mr. You also provides law enforcement biosecurity outreach by serving on the Strategic Advisory Board for the Synthetic Biology and Engineering Research Center and as an instructor for the United Nations Interregional Crime and Justice Research Institute. Prior to joining the FBI, Mr. You worked for six years in graduate research focusing on retrovirology and human gene therapy at the University of Southern California, Keck School of Medicine. He subsequently worked for three years at the biotechnology firm AMGEN Inc. in cancer research.

The webinar is an information-gathering meeting for the committee in which the speakers are invited to provide input to the committee. The webinar will be recorded and posted on this page.

Third Public Meeting

The committee held its third public meeting on Monday, June 27, 2016 at the Sir Francis Drake Hotel, 450 Powell Street, San Francisco, CA 94102.

Click the links below to view webcast recordings.


 Sessions include 10 minute presentations from each panelist followed by panel discussion

Monday, June 27

8:30 am Welcome and Introductions


8:30 – 9:50 am

Moderator: Rick Johnson


9:50 am BREAK


10:10 – 11:30 am

Moderator: Mary Maxon


11:30 am LUNCH


12:30 – 1:50 pm

Moderator: David Rejeski


1:50 pm BREAK


2:05 – 3:25 pm

Intentionally Released Biotechnologies

Moderator: Richard Murray


3:25 pm BREAK

3:40 – 5:00 pm

Biotechnologies Intended for Contained Use

Moderator: Jennifer Kuzma


5:00 pm  BREAK

5:15 pm  Public Comment Period

5:30 pm  Adjourn Open Session

*presentation given remotely